Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.09%, DAX (0.02%), CAC40 (0.04%)

Apr 17 ,2026

  • Synopsis

    • European indices are set to open mostly unchanged as Asian equities trade mostly lower Friday. Benchmarks turning lower following three-day rally built largely on US-Iran diplomatic traction. Japan, South Korea and Hong Kong seeing biggest declines. Taiwan weighed down by TSMC. S&P 500 futures flat afterhours.

    • Iran conflict de-escalation signals continue to drive risk sentiment with latest headlines noting US and Iran have agreed in-principle to extend ceasefire beyond next week's deadline to allow more time for diplomacy.

    • Lot of central bank commentary to digest in Europe. ECB source report said officials leaning towards keeping policy unchanged at the end of this month, as incoming data won't offer enough clarity on economic impact of Iran conflict. Both Schnabel and Villeroy signaled caution. March ECB minutes highlights need for evidence before acting on energy shock. BoE Governor Bailey reiterated that he is no rush to raise interest rates, reinforcing expectations of steady hand.

    • Earnings reported this morning: (ERIC.B.SS) Telefonaktiebolaget LM Ericsson reports Q1 EBIT SEK5.21B ex-items vs consensus SEK5.41B. (WHA.NA) Wereldhave Q1 trading update: reports direct result per share (DRPS) € 0.45, +2.3% y/y.

    • Economic expected today: Italy Feb trade balance, Eurozone Feb trade balance

  • Politics/Macro/World News

    • The ECB Needn't Make Europe's Energy Shock Worse (BBG )

    • Trump says Iran war should end 'soon', both sides may meet at weekend (Reuters )

  • Top company news

    • Earnings/updates

      • DG.FP (VINCI SA) -- Vinci reports March airport passenger traffic +1.6%

      • ALO.FP (Alstom) -- reports preliminary FY revenue €19.2B vs FactSet €19.01B [13 est, €18.86-19.42B]

      • PIRC.IM (Pirelli & C.) -- reaffirms FY guidance with adj. EBIT expected at the lower end of guidance; activated mitigation plan to contain the impacts of the crisis in the Middle East (~12:02ET)

      • ADP.FP (Aeroport de Paris) -- reports Total Paris Aeroport March traffic 8.3M, +3.4% y/y

      • VIRP.FP (Virbac) -- reports Q1 revenue €384M, +2% vs year-ago €375M

      • DRW3.GR (Drägerwerk) -- reports preliminary Q1 EBIT €18M vs year-ago €0.4M

      • MMB.FP (Lagardere) -- reports Q1 revenue €2.04B, +3% vs year-ago €1.98B

      • IPS.FP (Ipsos) -- reports Q1 revenue €554.9M vs FactSet €572.3M [1 est]

      • ICAD.FP (Icade) -- reports Q1 revenue €278.2M, (15%) vs year-ago €326.0M

      • WHA.NA (Wereldhave) -- Q1 trading update: reports direct result per share (DRPS) € 0.45, +2.3% y/y

      • NYR.BB (Nyrstar) -- reports FY operating profit (€2.9M) vs year-ago (€4.5M)

      • OVS.IM (OVS) -- reports FY adjusted net income €89.4M vs FactSet €89.8M

      • GURN.SW (Gurit Holding) -- reports Q1 revenue CHF75.9M vs FactSet CHF73.1M [1 est]

      • THEP.FP (Thermador Groupe) -- reports H1 revenue €142.4M, +10% vs year-ago €129.9M

    • M&A

      • EQT.SS (EQT AB) -- EQT re-launches sale process for China business of contact lens manufacturer Ginko -- Reuters (earlier, timing uncertain)

      • DOV.IM (doValue) -- completes acquisition of coeo (~10:05ET)

      • KNEBV.FH (Kone) -- reportedly in advanced discussions to purchase TK Elevator -- Bloomberg

      • LOCAL.FP (Solocal Group) -- Solocal announces the planned acquisition of Artur'In, the AI platform dedicated to small and medium-sized businesses. Terms not disclosed

      • COMB.BB (Compagnie du Bois Sauvage) -- Compagnie du Bois Sauvage completes acquisition of remaining 34% stake in Jeff de Bruges

      • O5G.GR (CPI PROPERTY GROUP) -- CPI Property Group announces approval of offer document concerning previously announced voluntary tender offer for Next Re; acceptance period to commence on 20-Apr

    • Healthcare

      • AZN.LN (AstraZeneca) -- FDA approves Wainua sNDA for pre-filled syringe

      • OXB.LN (OXB) -- Transcript Intelligence: OXB at Needham Virtual Healthcare Conference

      • AB.FP (AB Science) -- provides clinical program update; secures €25M clinical trial insurance for phase III trial in AMYOTROPHIC lateral sclerosis, discloses associated voluntary temporary halt of clinical trials in EU

      • PHO.NO (PhotoCure) -- Transcript Intelligence: PhotoCure at Needham Virtual Healthcare Conference

    • Other

      • DIE.BB (D'Ieteren Group) -- Belron targeting Amsterdam IPO at valuation of over €30B - FT (16-Apr, seemingly around 15:55 CEST)

      • ICAD.FP (Icade) -- Follow-up: Icade reports Q1 revenue; Chairman Frédéric Thomas' term to end on 10-Jun

      • ASML.NA (ASML Holding) -- Street Takeaways - ASML Holding Q1 Earnings

      • ERIC.B.SS (Telefonaktiebolaget LM Ericsson) -- initiates share buyback program of up to SEK 15.00B

      • GIVN.SW (Givaudan) -- Street Takeaways - Givaudan Q1 Sales

      • REP.SM (Repsol) -- issues press release on agreement to increase its oil production in Venezuela

      • ALO.FP (Alstom) -- CORRECTION: Alstom reports preliminary FY revenue €19.2B vs FactSet €19.01B

      • AGS.BB (Ageas) -- releases 2025 Annual Report (includes sustainability report)

      • Israel-Lebanon agree to temporary truce; Anthropic releases new model in intraday themes (16-Apr)

      • Regional Gaming Revenues - New Jersey March 2026

      • Wall Street banks offering CDS against private credit funds run by Apollo, Ares and Blackstone - FT

  • Key rating changes

    • Upgrades

      • BOSN.SW (Bossard Holding) -- to neutral from sell at UBS

    • Downgrades

      • ALO.FP (Alstom) -- to hold from buy at Deutsche Bank

      • YAR.NO (Yara International) -- to hold from buy at DNB Carnegie

      • NHY.NO (Norsk Hydro) -- to equal-weight from overweight at Morgan Stanley

      • KINV.B.SS (Kinnevik) -- to hold from buy at DNB Carnegie

    • Initiations

      • SKA.B.SS (Skanska) -- buy at Deutsche Bank

    • Other Actions

      • AT1.GR (Aroundtown) -- resumed underweight at Morgan Stanley

      • CIRSA.SM (Cirsa Enterprises) -- resumed outperform at Bernstein

  • Data

    • Nikkei (0.96%) to 58946.16

    • Hang Seng (1.27%) to 26060.33

    • Shanghai Composite (0.20%) to 4047.62

    • S&P futures +1.8 vs prior close of 7077.0

    • €-$ +0.0002 or +0.02% to 1.1784

    • $-¥ +0.33 or +0.21% to 159.49

    • €-¥ +0.40 or +0.21% to 187.91

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.